|
[1]
|
侯清涛, 李芸, 李舍予. 全球糖尿病疾病负担现状[J]. 中国糖尿病杂志, 2016, 24(1): 92-96.
|
|
[2]
|
American Dia-betes A. (2021) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44, S15-S33. [Google Scholar] [CrossRef]
|
|
[3]
|
Okamoto, Y., Kihara, S., Ouchi, N., et al. (2002) Adi-ponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation, 106, 2767-2770. [Google Scholar] [CrossRef]
|
|
[4]
|
Yamauchi, T., Kamon, J., Waki, H., et al. (2001) The Fat-Derived Hormone Adiponectin Reverses Insulin Resistance Associated with Both Lipoatrophy and Obesity. Nature Medicine, 7, 941-946. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Matsuda, M., Shimomura, I., Sata, M., et al. (2002) Role of Adiponectin in Preventing Vascular Stenosis. The Missing Link of Adipo-Vascular Axis. Journal of Biological Chemistry, 277, 37487-37491. [Google Scholar] [CrossRef]
|
|
[6]
|
Tanimura, D., Shibata, R., Izawa, H., et al. (2011) Relation of a Common Variant of the Adiponectin Gene to Serum Adiponectin Concentration Andmetabolic Traits in an Aged Japa-nese Population. European Journal of Human Genetics, 19, 262-269. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Schäffler, A., Barth, N., Palitzsch, K.D., et al. (2000) Mutation Analy-sis of the Human Adipocytes Pecicapm-1gene. EurClinInvest, 30, 879-887. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ceriello, A. (2003) New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy. Diabetes Care, 26, 1589-1596. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
徐丽英, 钟萍, 曹烨民. 脂联素与糖尿病及其并发症的关系研究[J]. 中国医药导报, 2018, 15(28): 29-32.
|
|
[10]
|
Kacso, I., Lenghel, A., Bondor, C.L., et al. (2012) Low Plasma Adiponectin Levels Predict Increased Urinary Albumin/Creatinine Ratio in Type 2 Diabetes Patients. International Urol-ogy and Nephrology, 44, 1151-1157. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Saraheimo, M., Forsblom, C., Fagerud, J., et al. (2005) Serum Adiponectin Is Increased in Type 1 Diabetic Patients with Nephropathy. Diabetes Care, 28, 1410-1414. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Kacso, L.I.M., Bondor, C.L. and Kacso, G. (2012) Plasma Adi-ponectin Is Related to the Progression of Kidney Disease in Type 2 Diabetes Patients. Scandinavian Journal of Clinical and Laboratory Investigation, 72, 333-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Saraheimo, M., Fosblom, C., Thorn, L., et al. (2008) Serum Adiponectin and Progression of Diabetic Nephropathy in Patients with Type 1 Diabetes. Diabetes Care, 31, 1165-1169. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Prior, S.L., Tang, T.S., Gill, G.V., et al. (2011) Adiponectin, Total Antiox-idantstatus and Urine Albumin Excretion in the Low-Risk “Golden Years” Type 1 Diabetes Mellitus Cohort. Metabolism: Clinical and Experimental, 60, 173-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
lwal, N., et al. (2004) Genetic Analysis of 22 Candidate Genes for Hypertension in the Japanese Population. Journal of Hypertension, 2, 1119-1126. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zadal, F., Al-Yahyae, S., Hassan, M.O., Albarwani, S. and Bayoumil, R.A. (2013) Association of Adiponectin Promoter Variants with Traits and Clusters of Metabolic Syn-drome in Arabs: Family-Based Study. Gene, 527, 663-669. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kishore, S.P., Salam, A., Rodgers, A., et al. (2018) Fixed-Dose Combinations for Hypertension. The Lancet, 392, 819-820. [Google Scholar] [CrossRef]
|
|
[18]
|
Iacoviello, M., Forleo, C., Sorrentino, S., et al. (2006) α- and β-Adrenergic Receptor Polymorphisms in Hypertensive and Normotensive Offspring. Journal of Cardiovascular Medi-cine, 7, 316-321. [Google Scholar] [CrossRef]
|
|
[19]
|
Zhang, B., et al. (2011) Association between Single Nucleotide Polymormphisms (SNPs) at the Promoter of Adiponectin Gene and Essential Hypertension in Chinese Kore-an and Han of Yanbian Region. Hereditas (Yi Chuan), 33, 54-59. (In Chinese) [Google Scholar] [CrossRef]
|
|
[20]
|
Machado, J.S., et al. (2014) Polymorphisms of the Adiponectin Gene in Gestational Hypertension and Pre-Eclampsia. Journal of Human Hypertension, 28, 128-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Jiang, B., et al. (2014) Association of Four Insulin Resistance Genes with Type 2 Diabetes Melltus and Hypertension in the Chinese Han Population. Molecular Bioloary Reports, 41, 925-933. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Avery, P.J., Patel, S.K., lbrahim, I.M., Walker, M. and Keavney, B.D. (2011) Common Variation in the Adiponectin Gene Has an Effect on Systolic Blood Pressure. Journal of Hunan Hypertension, 25, 719-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ong, K.L., et al. (2010) Association of Genetic Variants in the Adi-ponectin Gene with Adiponectin Level and Hypertension in Hong Kong Chinese. European Journal of Endocrinolo-gy/European Federation of Endocrine Societies, 163, 251-257. [Google Scholar] [CrossRef]
|
|
[24]
|
Hara, K., et al. (2002) Genetic Variation in the Gene Encoding Adiponectin Is Associated with an Increased Risk of Type 2 Diabe-tes in the Japanese Population. Diabetes, 51, 536-540. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Bai, Y., et al. (2010) Relationships among Adiponectin Gene Polymorphisms, Proteinuria and Increased Blood Pressure in the Context of Placental Diseases. Hypertension Research, 33, 106-1070. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Weyer, C., Funabashi, T., Tanaka, S., et al. (2001) Hypocdiponeetinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. The Journal of Clini-cal Endocrinology & Metabolism, 86, 1930-1935. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
郭燕, 蔡艳, 白云霞, 等. 血清脂联素、胰岛素抵抗与代谢综合征的相关性研究[J]. 中国实用医药, 2016, 11(29): 8-10.
|
|
[28]
|
Ford, E.S. Giles, W.H. and Dietz, W.H. (2002) Prevalence of the Metabolic Syndrome among US Adults: Findings from the Third National Health and Nutrition Examination Survey. The Journal of the American Medical Association, 287, 356-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Reaven, G.M. (2005) The Insulin Resistance Syndrome: Definition and Dietary Approaches to Treatment. Annual Review of Nutrition, 25, 391-406. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Galassi, A., Reynolds, K. and He, J. (2006) Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis. The American Journal of Medicine, 119, 812-819. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Gami, A.S., Witt, B.J., Howard, D.E., Erwin, P.J., Gami, L.A., Somers, V.K. and Montori, V.M. (2007) Metabolic Syndrome and Risk of Incident Cardio-Vascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of the American College of Cardiology, 49, 403-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Scherer, P.E., Williams, S., Fogliano, M., Baldini, G. and Lodish, H.F. (1995) A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes. Journal of Biological Chemis-try, 270, 26746-26749. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Hu, E., Liang, P. and Spiegelman, B.M. (1996) AdipoQ Is a Novel Adipose-Specific Gene Dysregulated in Obesity. Journal of Biological Chemistry, 271, 10697-10703. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Spranger, J., Kroke, A., Mohlig, M., Bergmann, M.M., Ristow, M., Boeing, H. and Pfeiffer, A.F. (2003) Adiponectin and Prolection against Type 2 Diabetes Mellitus. The Lancet, 361, 226-228. [Google Scholar] [CrossRef]
|
|
[35]
|
Laughlin, G.A., Barett-Connor, E., May, S. and Langenberg, C. (2007) Association of Acliponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study. Ameri-can Journal of Epidemiology, 165, 164-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Iwwashima, Y., Katsuya, T., Ishikawa, K., Ouchi, N., Ohishi, M., Sugimoto, K., Fu, Y., Motone, M., Yamamoto, K., Matsuo, A., Ohashi, K., Kihara, S., Funahashi, T., Rakugi, H., Matsuzawa, Y. and Ogihara, T. (2004) Hypoadiponectinemia Is an Independent Risk Factor for Hypertension. Hyperten-sion, 43, 1318-1323. [Google Scholar] [CrossRef]
|
|
[37]
|
Hong, S.J., Park, C.G., Seo, H.S., Oh, D. and Ro, Y.M. (2004) Associations among Plasma Adiponectin, Hypertension, Left Ventricular Diastolic Function and Left Ven-tricular Mass Index. Blood Pressure, 13, 236-242. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F.A., Cutrupi, S., Parlongo, S., Malatino, L.S., Bonanno, G., Seminara, G., Rapisarda, F., Fatuzzo, P., Buemi, M., Nicocia, G., Tanaka, S., Ouchi, N., Kihara, S., Funahashi, T. and Matsuzawa, Y. (2002) Adiponectin, Metabolic Risk Factors and Cardiovas-cular Events among Patients with End-Stage Renaldisease. Journal of the American Society of Nephrology, 13, 134-141. [Google Scholar] [CrossRef]
|
|
[39]
|
Pischon, T., Girman, C.I., Hotamisligil, G.S., Rifai, N., Hu, F.B. and Rimm, E.B. (2004) Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men. JAMA, 291, 1730-1737. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Golledge, J., Leicht, A., Crowther, R.G., Clancy, P., Spinks, W.L. and Quigley, F. (2007) Association of Obesity and Metabolic Syndrome with the Severity and Outcome of Intermittent Claudication. Journal of Vascular Surgery, 45, 40-46. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Iwashima, Y., Horio, T., Suzuki, Y., Kihara, S., Rakugi, H., Kangawa, K. Funahashi, T., Ogihara, T. and Kawano, Y. (2006) Adi-ponectin and Inflammatory Markers in Peripheral Arterial Occlusive Disease. Atherosclerosis, 188, 384-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Robinson, K., Prins, J. and Venkatesh, B. (2011) Clini-cal Review: Adiponectin Biology and Its Role in Inflammation and Critical Illness. Critical Care, 15, Article No. 221. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Yamauchi, T., Kamon, J., Minokoshi, Y., lto, Y., Waki, H., Uchidas, Y.S., Noca, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Fere, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B. and Kadowaki, T. (2002) Adiponectin Stimulates Glucose Utilization and Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase. Nature Medicine, 8, 1288-1295. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Joshi, M.B., Philippova, M., Ivanov, D., Allenspach, R., Erne, P. and Resink, T.J. (2005) T-Cadherin Protects Endothelial Cells from Oxidative Stress-Induced Apoptosis. FASEB Journal, 19, 1737-1749. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Shimomura, I, Muraguchi, M., Ohmoto, Y., Fu-nahashiapos, T. and Matsuzawa, Y. (2002) Adipocyte-Derived Plasma Protein Adiponectinacts as a Platelet-Derived Growth Factor-BB-Binding Protein Andregulates Growth Factor-Induced Common Postreceptor Signal Invascular Smooth Muscle Cell. Circulation, 105, 2893-2898. [Google Scholar] [CrossRef]
|
|
[46]
|
Trayhurn, P. and Wood, S. (2004) Adipokines: In-flammation and the Pleiotropic Role of White Adipose Tissue. British Journal of Nutrition, 92, 347-355. [Google Scholar] [CrossRef]
|
|
[47]
|
Lenz, A. and Diamond Jr., F.B. (2008) Obesity: The Hormonal Milieu. Current Opinion in Endocrinology, Diabetes and Obesity, 15, 9-20. [Google Scholar] [CrossRef]
|
|
[48]
|
Tian, F., Luo, R., Zhao, Z., Wu, Y. and Ban, D.J. (2010) Blockade of the RAS Increases Plasma Adiponectin in Subjects with Metabolic Syndrome and Enhances Differentiation and Adiponectin Expression of Human Preadipocytes. Experimental and Clinical Endocrinology & Diabetes, 118, 258-265. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Chandran, M., Phillips, S.A., Ciaraldi, T. and Henry, R.R. (2003) Adiponectin: More than Just another Fat Cell Hormone? Diabetes Care, 26, 2442-2450. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Díez, J. and Igllesias, P. (2003) The Role of the Novel Adipo-cyte-Dlerived Hormone Adiponectin in Human Disease. European Journal of Endocrinology, 148, 293-300. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Tiikkainen, M., H äkkinen, A.-M., Korsheninnikova, E., Nyman, T., Mäkimattila, S. and Yki-Järvinen, H. (2004) Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insu-lin Resistance, Insulin Clearance, and Gene Expression Inadipose Tissuc in Patients with Type 2 Diabetes. Diabetes, 53, 2169-2176. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Miyazaki, Y., Mahankali, A., Wajcberg, E., Bajaj, M., Mandarino, L.J. and DeFronzo, R.A. (2004) Effect of Pioglitazone on Circulating Adipocytokine Levels and Insulin Sensitivity in Type 2 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism, 89, 4312-4319. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Shinmura, K., Tamaki, K., Saito, K., Nakano, Y., Tobe, T. and Bolli, R. (2007) Cardioprotective Effects of Shor-Term Caloric Restriction Are Mediated by Adiponectin via Activation of AMP-Activated Protein Kinase. Circulation, 116, 2809-2817. [Google Scholar] [CrossRef]
|
|
[54]
|
Gómez-Arbeláez, D. Lahera, V., Oubiña, P., Valero-Muñoz, M., de Las Heras, N., Rodriguez, Y., García, R.G., Camacho, P.A. and López-Jaramillo, P. (2013) Aged Garlic Extract Improves Adiponectinlevels in Subjects with Metabolic Syndrome: A Double-Blind, Placebo-Controlled, Randomized, Crossover Study. Mediators of Inflammation, 2013, Article ID: 285795. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Decleves, A.E., Mathew, A.V., Cunard, R., et al. (2011) AMPK Medi-ates the Initiation of Kidney Disease Induced by a High-Fat Diet. Journal of the American Society of Nephrology: JASN, 22, 1846-1855. [Google Scholar] [CrossRef]
|
|
[56]
|
Shibata, R., Ouch, N. and Murohara, T. (2009) Adiponectin and Cardiovascular Disease. Circulation Journal, 73, 618-614. [Google Scholar] [CrossRef]
|
|
[57]
|
Mallamaci, F., Zoccali, C., Cuzzola, F., et al. (2002) Adiponectin in Essential Hypertension. Journal of Nephrology, 15, 507-511.
|
|
[58]
|
Adamczak, M., Czerwienska, B., Chudek, J. and Wiecek, A. (2007) Renal Extraction of Circulating Adi-ponectin in Patients with Renovascular Hypertension. Acta Physiologica Hungarica, 94, 143-148. [Google Scholar] [CrossRef]
|
|
[59]
|
Lwashima, Y., Horio, T., Kumada, M., et al. (2006) Adi-ponectin and Renal Function and Implication as a Risk of Cardiovascular Disease. The American Journal of Cardiology, 98, 1603-1608. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Ignacy, W., Chudiek, J., Adamczak, M., et al. (2005) Recipro-cal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease: A Follow-Up Study. Nephron Clinical Practice, 101, c18-c24. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Marchlewska, A., Stenvinkel, P., Lindholm, B., et al. (2004) Reduced Gene Expression of Adiponectin in Fat Tissue from Patients with End-Stage Renal Disease. Kidney International, 66, 46-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Shen, Y.Y., Charlesworth, J.A., Kelly, J.J., Loi, K.W. and Peake, P.W. (2007) Up-Regulation of Adiponectin, Its Isoforms and Receptors in End-Stage Kidney Disease. Nephrolo-gy, Dialysis, Transplantation, 22, 171-178. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Tsigalou, C., Chalikias, C., Kantartzi, K., et al. (2013) Differential Effect of Baseline Adiponectin on All-Cause Mortality in Hemodialysis Patients Depending on Initial Body Mass Index. Long-Term Follow-Up Data of 4.5 Years. Journal of Renal Nutrition, 23, 45-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Ldorn, T., Hormum, M., Bjere, M., et al. (2012) Plasma Adiponectin before and after Kidney Transplantation. Transplant International, 25, 1194-1203. [Google Scholar] [CrossRef] [PubMed]
|